Outcome of 01st Extra-Ordinary General Meeting of Eiko Lifesciences Limited held on 07th January, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences held its 1st Extra-Ordinary General Meeting (EOGM) on 7 January 2026 via video conferencing, attended by 21 members. Two special resolutions were passed: (1) issuance of 33,00,000 warrants convertible into equity shares on a preferential basis, and (2) issuance of 6,75,000 equity shares on a preferential basis. Allotments under both resolutions are proposed to persons belonging to the Promoter/Promoter Group and Non-Promoter/Public categories. The Chairperson, Mr. Laxmikant Kabra, also spoke about the company's plan to acquire SSM Formulations Private Limited and highlighted areas of expected growth opportunities. The meeting concluded at 03:34 PM with e-voting open till 03:49 PM. Quorum was present throughout, and all resolutions were transacted as per the EOGM notice.
The preferential issue of warrants (33 lakh) and equity shares (6.75 lakh) will lead to dilution of existing shareholders once the warrants are converted. The acquisition of SSM Formulations may expand the business but success and pricing details will determine whether it is value-accretive or value-dilutive for current shareholders.